A Move in the Light Direction

What Safety Measures Will Guests Expect as Travel Booms this Summer?

On this episode of A Move In The Light Direction, a podcast by Surfacide UV Technology, host Daniel Litwin talked with Wendy Walling, Director of Global Marketing at Intellego Technologies, and Jeff Veenhuis, President and CEO, Surfacide Manufacturing. The trio spoke about trends in summer travels as the U.S. meets new highs in travel demand…

Read More

Latest

A Move in the Light Direction
Is UVC the Future of Infection Prevention Technology?

The risk of cross-contamination and mass infections in healthcare settings has always been an issue, but in the midst of a raging pandemic, that problem has been exacerbated even further. However, with many hospitals, nursing homes and other healthcare facilities already stretched thin, an affordable solution that requires minimal time and effort to use is…

Read More
A Move in the Light Direction
Easing the PPE Strain During the Pandemic

During the early days of the pandemic, one of the healthcare community’s challenges was a critical lack of PPE to fight the coronavirus. Ryan Madewell, Director of Environmental Services at Hunt Regional Healthcare for Vanguard Resources, spoke about this problem and how Surfacide’s UV-C solutions helped keep front-line workers and patients safe. Even before…

Read More
A Move in the Light Direction
How Healthcare Organizations Are Navigating Compliance Challenges during the COVID Pandemic

The COVID-19 pandemic has strained healthcare systems and those who work in them all over the world. But, with more patients and more work, there cannot be a reduction in standards or compliance. Rich Feczko, National Director of Standards & Innovation for Compass One Healthcare, is one of many mourning the recent loss of…

Read More
A Move in the Light Direction
UV-C’s Role in Fighting COVID-19

Multidrug-resistant pathogens are an increasing concern in healthcare. Finding new ways and technologies to fight these pathogens is what led Gunner Lyslo to create Surfacide UV-C, an infection prevention solution. Lyslo, Founder and CEO of Surfacide, spoke to Tyler Kern about the technology’s ability to play a role in fighting COVID-19. Lyslo developed Surfacide…

Read More

Latest

ESA
ESA Success Requires Strategy, Infrastructure, and Support Beyond Legislation
April 21, 2025

As education savings accounts (ESAs) gain traction across the United States, the conversation is shifting from policy debates to the complexities of implementation. Fueled by post-pandemic dissatisfaction with traditional school models and a desire for more customizable educational options, ESAs are being adopted in a growing number of states, often under “universal” frameworks. But…

Read More
supply chain data analytics
Supply Chain Data Analytics Fails Without Clean Data, Ventagium Delivers the Fix
April 21, 2025

Supply chain leaders face an overwhelming volume of siloed data across ERPs, TMS platforms, and warehouse systems, yet few know how to align it for smarter decisions. The stakes are rising fast. According to Capgemini’s 2024 report Data: A Powerful Ally in Tackling Scope 3 Emission Reduction Targets, 85% of organizations cite data access…

Read More
cancer immunotherapy
What’s Next in Preclinical Cancer Immunotherapy Research?
April 19, 2025

As the field of cancer immunotherapy rapidly evolves, researchers are turning to next-generation in vitro technologies to replicate the complexities of the tumor microenvironment with unprecedented fidelity. Organoid platforms and ex vivo patient-derived tissue models are transforming how scientists approach preclinical testing, offering deeper mechanistic insights and better predictive power for therapeutic response. With immunotherapies…

Read More
vitro
Analyzing the Suppressive TME in In Vitro Based Assays
April 19, 2025

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

Read More